Stock ScreenerStock IdeasStock ForecastsStock Predictions & Stock Market Forecast 2026, 2027, 2028, 2029, 2030View analyst forecasts, price targets, buy/sell ratings, revenue/earnings forecasts and more
Stock ScreenerStock IdeasStock Forecasts
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FJDIU | ARC GROUP SECURITIES ACQUISITION I | $9.97 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$86.70k | -0.02 | N/A | N/A | ||
| IMC | IMC RARE EARTHS LTD | $10.27 | N/A | N/A | -342.33x | N/A | N/A | N/A | N/A | -$2.70M | -0.25% | -$7.09M | -0.07 | N/A | N/A | ||
| QMLS | QUMULUSAI INC | $5.89 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $14.86M | 0.47 | N/A | N/A | ||
| BIOT | INSTINCT BIO TECHNICAL CO INC | $0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $2.10M | 0.07 | N/A | N/A | ||
| REF | REFORMATION INC | $14.48 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $452.58M | 9.09 | N/A | N/A | ||
| PLCI | PELICAN ACQUISITION II CORP | $9.87 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$823.00 | 0.00 | N/A | N/A | ||
| BRAI | BRAIIN LTD | $5.31 | N/A | N/A | N/A | 520.59x | N/A | N/A | N/A | -$1.20M | -0.11% | -$4.78M | -0.02 | N/A | N/A | ||
| PNAQ.U | PINNACLE ACQUISITION CORP | $9.95 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$11.94k | -0.01 | N/A | N/A | ||
| VCRE | VICORE PHARMA HOLDING AB | $11.50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $104.53M | 0.37 | N/A | N/A | ||
| NUR | NURAN WIRELESS INC | $2.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $2.27M | 0.17 | N/A | N/A | ||
| CUVL | CLINUVEL PHARMACEUTICALS LTD | $7.42 | $2.80 | 165.23% | 16.13x | N/A | 6.08x | N/A | 4.75x | $27.10M | 7.29% | $156.74M | 3.13 | N/A | N/A | ||
| AZUL | AZUL SA | $7.50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$760.96M | -4.17 | N/A | N/A | ||
| LTGO | LATIGO BIOTHERAPEUTICS INC | $22.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$252.58M | -0.28 | N/A | N/A | ||
| LYNX | LYNTRIS INC | $15.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $56.86M | 0.49 | N/A | N/A | ||
| XIIIU | CHURCHILL CAPITAL CORP XIII | $10.51 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $3.29k | 0.00 | N/A | N/A | ||
| ATTO | ATTOVIA THERAPEUTICS INC | $20.62 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$125.52M | -30.22 | N/A | N/A | ||
| SCTX | SCRIBE THERAPEUTICS INC | $37.25 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$158.74M | -64.51 | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.